Lundbeck
HLUN-B.CO
#2403
Rank
A$9.36 B
Marketcap
$9.78
Share price
-0.36%
Change (1 day)
28.74%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Net assets

Net assets on the balance sheet as of June 2024 : A$5.17 Billion

According to Lundbeck 's latest financial reports the company has A$5.17 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lundbeck - Net assets on balance sheet (from 2009 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$4.79 B8.98%
2022-12-31$A$4.39 B14.55%
2021-12-31$A$3.83 B5.2%
2020-12-31$A$3.64 B1.53%
2019-12-31$A$3.59 B15.95%
2018-12-31$A$3.09 B23.22%
2017-12-31$A$2.51 B32.1%
2016-12-31$A$1.90 B7.75%
2015-12-31$A$1.76 B-34.53%
2014-12-31$A$2.69 B-3.53%
2013-12-31$A$2.79 B24.26%
2012-12-31$A$2.25 B3.74%
2011-12-31$A$2.17 B11.09%
2010-12-31$A$1.95 B3.51%
2009-12-31$A$1.88 B-5.57%
2008-12-31$A$1.99 B24.3%
2007-12-31$A$1.60 B5.7%
2006-12-31$A$1.52 B-6.14%
2005-12-31$A$1.62 B-12.09%
2004-12-31$A$1.84 B